Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Leishmaniasis, American”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Large-scale testing (Phase 3)Study completedNCT03096457
What this trial is testing

Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

Who this might be right for
Leishmaniasis, CutaneousLeishmania Braziliensis ComplexLeishmaniasis, American+1 more
Fundacion Nacional de Dermatologia 80
Large-scale testing (Phase 3)UnknownNCT01301937
What this trial is testing

Low Antimonial Dosage in American Mucosal Leishmaniasis

Who this might be right for
Mucosal LeishmaniasisMucocutaneous Leishmaniasis
Oswaldo Cruz Foundation 76
Testing effectiveness (Phase 2)Study completedNCT03294161
What this trial is testing

Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis

Who this might be right for
LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
Hospital Universitário Professor Edgard Santos 50
Large-scale testing (Phase 3)UnknownNCT06011343
What this trial is testing

Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 22
Large-scale testing (Phase 3)Looking for participantsNCT06040489
What this trial is testing

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

Who this might be right for
Leishmaniasis; BrazilianLeishmaniasis, Mucocutaneous
University of Brasilia 100
Not applicableStudy completedNCT05533736
What this trial is testing

Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia

Who this might be right for
Cutaneous Leishmaniasis, American
Centro Internacional de Entrenamiento e Investigaciones Médicas 105
Testing effectiveness (Phase 2)Study completedNCT06000514
What this trial is testing

Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 20
Large-scale testing (Phase 3)Study completedNCT03829917
What this trial is testing

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis, American
Fundacion Nacional de Dermatologia 120
Large-scale testing (Phase 3)Study completedNCT04515186
What this trial is testing

Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Who this might be right for
Cutaneous Leishmaniases
Drugs for Neglected Diseases 184
Not applicableNo Longer AvailableNCT00508963
What this trial is testing

Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

Who this might be right for
Leishmaniasis, CutaneousLeishmaniasis, Mucocutaneous
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT06449040
What this trial is testing

Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06997159
What this trial is testing

A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).

Who this might be right for
Localized Cutaneous Leishmaniasis
Drugs for Neglected Diseases 250
Testing effectiveness (Phase 2)UnknownNCT03084952
What this trial is testing

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

Who this might be right for
Leishmaniasis; American, CutaneousDrug Side Effect
Infan Industria Quimica Farmaceutica Nacional 52
Large-scale testing (Phase 3)Study completedNCT01301924
What this trial is testing

Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Oswaldo Cruz Foundation 72
Early research (Phase 1)Not Yet RecruitingNCT07149753
What this trial is testing

Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis

Who this might be right for
Cutaneous LeishmaniasisCutaneous Leishmaniasis, AmericanTopical Administration
Universidad Industrial de Santander 15